达芬奇机器人腹膜后肿瘤切除术50例临床分析

Clinical analysis of 50 cases of da Vinci robotic surgery system in retroperitoneal tumor resection

目的探讨通过达芬奇机器人系统行腹膜后肿瘤切除术的手术安全性、技术的可行性及其在临床上应用的价值.方法回顾性总结2016年10月至2021年12月青岛大学附属医院50例接受达芬奇机器人腹膜后肿瘤切除术患者的临床资料及治疗效果,分析手术时间、术中出血量、术后住院时间、并发症情况;并分析是否有主要血管黏附对手术时间、术中出血量、术后住院时间的影响.结果达芬奇机器人腹膜后肿瘤切除手术时间(159.7±52.18)min、术中出血量(33.1±23.25)ml,术后住院时间(4.32±1.34)d.肿瘤粘附或不粘附在主要血管之间的临床结局无显著性差异(P>0.05).结论手术后患者创伤小、住院时间短、术后并发症少,具有明显的优势,有较好的临床发展前景,值得推广应用.

Objective To explore the surgical safety,technical feasibility and clinical application value of retroperitoneal tumor resection with Da Vinci robot system.Methods Retrospective summary of the clinical data and treatment effect of 50 patients who received Leonardo da Vinci robot retroperitoneal tumor resection in the Affiliated Hospital of Qingdao University from October 2016 to December 2021,and analysis of the operation time,intraoperative blood loss,postoperative hospital stay,and complications The influence of major vascular adhesion on operation time,intraoperative blood loss and postoperative hospital stay was analyzed.Results The operation time of Da Vinci robot retroperitoneal tumor resection was(159.7±52.18)min,the intraoperative blood loss was(33.1±23.25)ml,and the postoperative hospital stay was(4.32±1.34)d.There was no significant difference in clinical outcome between vessels with or without tumor adherence(P>0.05).Conclusions Postoperative patients have obvious advantages,such as less trauma,shorter hospital stay and fewer postoperative complications.They have good clinical development prospects and are worthy of promotion and application.